Skip to Content

Join the 'Osteolytic Bone Metastases of Breast Cancer' group to help and get support from people like you.

Osteolytic Bone Metastases of Breast Cancer News

Related terms: Bone Metastases of Breast Cancer

'Nipple-Sparing' Mastectomies Don't Raise Odds of Cancer's Return: Study

Posted 19 Jul 2017 by Drugs.com

WEDNESDAY, July 19, 2017 – Surgeons performing mastectomies can offer a form of the procedure that allows women to retain the nipple for use in breast reconstruction. Now, a reassuring study finds that this type of mastectomy doesn't raise a woman's risk for breast cancer recurrence. "More women are requesting nipple-sparing mastectomy because of the superior cosmetic results. But doctors don't want to take any chances with breast cancer patients' safety for the sake of cosmetic improvement," explained lead researcher Dr. Barbara Smith. She's a surgical oncologist and director of the breast program at Massachusetts General Hospital in Boston. "Our study, which has one of the longest reported follow-ups after therapeutic nipple-sparing mastectomy in the United States, provides additional support that it's safe to leave the nipple intact during mastectomy with only a few exceptions," she ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Surgical Prophylaxis, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

Asian Women Less Likely to Get Follow-up After Abnormal Mammogram

Posted 12 Jun 2017 by Drugs.com

MONDAY, June 12, 2017 – Asian women in the San Francisco area were less likely than white women to get follow-up tests following an abnormal mammogram result, researchers report. Women who receive suspicious mammogram results are urged to get checked in a timely manner to rule out breast cancer, which should be treated as early as possible to ensure the best possible outcomes, the study authors said. However, the researchers, led by Kim Hanh Nguyen and Dr. Leah Karliner of the University of California, San Francisco, explained that many population-based breast cancer studies don't include Asians or differentiate among individual groups of patients. "Rather than being a monolithic group, Asians are, in fact, very diverse in nationalities, language, immigration history, education, and economic background. Recognizing differences among Asians may help clinicians develop better rapport and ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Yoga, Meditation May Ease Some Breast Cancer Symptoms

Posted 19 May 2017 by Drugs.com

FRIDAY, May 19, 2017 – The diagnosis and treatment of breast cancer can come with a lot of anxiety, depression and other symptoms that affect quality of life. But mind-body therapies, such as yoga or meditation, may help ease these troubling concerns, a new study suggests. The researchers reviewed previous studies done on 80 integrative therapies. "We have good evidence that [some] mind-body therapies – such as meditation, yoga, relaxation – can provide benefit to breast cancer patients during and after treatment," said study researcher Heather Greenlee. She's an assistant professor of epidemiology at Columbia University's Mailman School of Public Health. "And we do have evidence that acupuncture is very useful in managing pain," she added. Evidence about dietary supplements and botanicals, however, are lacking when it comes to helping symptoms and side effects, she said. Greenlee ... Read more

Related support groups: Depression, Cancer, Major Depressive Disorder, Breast Cancer, Breast Cancer, Metastatic, Dysthymia, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Breast Cancer - Male, Osteolytic Bone Metastases of Breast Cancer

More U.S. Women Living Longer With Advanced Breast Cancer

Posted 18 May 2017 by Drugs.com

THURSDAY, May 18, 2017 – The number of U.S. women living with the most advanced stage of breast cancer has been rising since the 1990s, a new study finds. Researchers say that treatment advances, allowing more breast cancer patients to survive longer, are one likely reason. The general aging of the U.S. population is another. Right now, the study estimated, close to 155,000 U.S. women are living with metastatic breast cancer – cancer that has spread beyond the breast to distant sites in the body. That is up from roughly 105,000 in 1990. Breast cancer experts said the figures are actually the first estimates of how many U.S. women are living with metastatic disease. A number has been hard to come by, they said, because there is no national system that tracks cancer recurrences: Since U.S. women are typically diagnosed with earlier-stage breast cancer, most metastatic cases would – ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

More Cancers Caught Early Since Obamacare

Posted 18 May 2017 by Drugs.com

THURSDAY, May 18, 2017 – More cancers have been spotted in their early stages since the Affordable Care Act (ACA) became the law of the land, new research finds. Finding breast, colon, cervical and lung cancers early greatly improves the odds of successful treatment, said study author Xuesong Han. She's the strategic director of health policy and health care delivery research at the American Cancer Society. "We wanted to see if the introduction of the ACA affected the diagnosis of these cancers," she said. Although the increase in early-stage cancer diagnosis was only 1 percent, it's a significant increase that includes thousands of patients whose cancer might not have been found until it was too late for effective treatment and potential cure, Han noted. The increases in diagnosis of lung and cervical cancer were mostly among people on Medicaid, she said. A large part of the ACA is ... Read more

Related support groups: Cancer, Breast Cancer, Lung Cancer, Colorectal Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Cervical Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer

Survival Continues to Improve for Most Cancers

Posted 31 Mar 2017 by Drugs.com

FRIDAY, March 31, 2017 – Overall cancer death rates in the United States continue to fall, but racial gaps persist, a new report says. Death rates fell between 2010 and 2014 for 11 of the 16 most common cancers in men and for 13 of the most common types in women, including lung, colon, prostate and breast cancers. However, death rates rose for cancers of the liver, pancreas and brain in men and for the liver and uterus in women. And improvements in cancer survival weren't equal for all Americans. "While this report found that five-year survival for most types of cancer improved among both blacks and whites over the past several decades, racial disparities for many common cancers have persisted, and they may have increased for prostate cancer and female breast cancer," said Dr. Lynne Penberthy. She's associate director of the U.S. National Cancer Institute's Surveillance Research ... Read more

Related support groups: Cancer, Breast Cancer, Prostate Cancer, Lung Cancer, Renal Cell Carcinoma, Colorectal Cancer, Non-Small Cell Lung Cancer, Breast Cancer, Metastatic, Brain Tumor, Melanoma, Pancreatic Cancer, Skin Cancer, Ovarian Cancer, Endometrial Cancer, Osteosarcoma, Small Cell Lung Cancer, Breast Cancer - Adjuvant, Bladder Cancer, Melanoma - Metastatic, Cervical Cancer

Exercise a Powerful Ally for Breast Cancer Survivors

Posted 21 Feb 2017 by Drugs.com

TUESDAY, Feb. 21, 2017 – For breast cancer survivors, exercise may help lower their chances of dying from the disease more than other healthy habits, a new review suggests. The Canadian researchers analyzed 67 published articles to see which habits made the most difference in reducing the risk of either breast cancer recurrence or death. Exercise came out on top, reducing the risk of breast cancer death by about 40 percent, said review author Dr. Ellen Warner, a medical oncologist at Sunnybrook Odette Cancer Centre and a professor at the University of Toronto. "It's similar to the magnitude of chemotherapy or hormone therapy," she said. "So, that's pretty powerful." However, the review did not prove that exercise causes breast cancer risk to drop. Besides exercise, the previous research looked at weight and weight gain, diet, smoking, alcohol and vitamin supplements. The new review ... Read more

Related support groups: Obesity, Weight Loss, Breast Cancer, Vitamin/Mineral Supplementation and Deficiency, Breast Cancer, Metastatic, Vitamin C, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Caltrate 600 with D, Breast Cancer - Palliative, Ascorbic Acid, Citracal + D, Calcium/Vitamin D, Citracal Petites, Vitron-C, Ester-C, Osteolytic Bone Metastases of Breast Cancer, Cecon, Protexin, Oysco 500 with D

Many Women Skip Mammograms After False-Positive Result

Posted 9 Feb 2017 by Drugs.com

THURSDAY, Feb. 9, 2017 – The trauma of receiving a false-positive result from a mammogram may lead many women to delay or skip their next screening, a new study finds. A false-positive result means that an aberration on a mammogram looks like it might be cancer. But after tests – such as added imaging or biopsy – it turns out to be benign. In the meantime, however, the patient may go through distress and various procedures, and decide to delay or skip her next mammogram. That's a potentially fatal mistake, breast cancer experts said, because detecting tumors early can save lives. "Unfortunately, for women over age 50, just skipping a mammogram every other year would miss up to 30 percent of cancers," said Dr. Stefanie Zalasin, a breast imaging specialist who reviewed the new findings. "Reassuring a patient that the overwhelming majority of mammograms and even biopsies are normal can ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Too Few High-Risk Women Tested for Breast Cancer Gene: Survey

Posted 7 Feb 2017 by Drugs.com

TUESDAY, Feb. 7, 2017 – Though testing for two genes that raise breast cancer risk has been around for decades, a new survey finds many high-risk women don't get the test, often because they aren't told to by their doctors. Among women with the highest risk, about eight of 10 said they wanted testing for the BRCA1 and BRCA2 mutations. But, "only about half of them actually got the testing they should get," said study author Dr. Allison Kurian, from Stanford University's School of Medicine. "Genetic cancer testing is not well matched to the medical needs of the patient, to a woman's risk of having a mutation," said Kurian, an associate professor of medicine and of health research and policy. Why the gap? About 56 percent of the high-risk women who were not tested said their doctors did not recommend it, the survey found. In addition to the test itself, genetic counseling can help ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Ovarian Cancer, Breast Cancer, Prevention, Breast Cancer - Palliative, Diagnosis and Investigation, Osteolytic Bone Metastases of Breast Cancer

Half Report Severe Side Effects From Breast Cancer Therapy

Posted 24 Jan 2017 by Drugs.com

TUESDAY, Jan. 24, 2017 – About half of early stage breast cancer patients experience severe side effects from their treatment, a new study finds. "It's in patients' best interest to receive their treatments on time and on schedule, whenever possible, to give them the best possible outcome," said study author Dr. Steven Katz. He's professor of health management and policy at the University of Michigan. "Unscheduled care for toxicities [side effects] – including clinic visits, emergency department visits and hospital stays – are expensive, inconvenient and disruptive to both doctors and patients. We need to avoid them whenever possible," Katz said in a university news release. For the study, researchers surveyed almost 2,000 early stage breast cancer patients an average of seven months after diagnosis. The women were asked to rate the severity of seven common treatment side effects: ... Read more

Related support groups: Surgery, Breast Cancer, Fluorouracil, Efudex, Breast Cancer, Metastatic, Carac, Herceptin, Taxol, Breast Cancer - Adjuvant, Taxotere, Carboplatin, Cyclophosphamide, Cytoxan, Breast Cancer, Prevention, Paclitaxel, Doxorubicin, Fluoroplex, Adriamycin, Breast Cancer - Palliative, Docetaxel

Study Casts More Doubt on Value of Mammograms

Posted 10 Jan 2017 by Drugs.com

MONDAY, Jan. 9, 2017 – Mammograms frequently detect small breast tumors that might never become life-threatening, causing women to receive treatment they likely don't need, a new Danish study finds. About one in every three women between the ages of 50 and 69 who was diagnosed with breast cancer wound up having a tumor that posed no immediate threat to her health, the researchers reported. At the same time, mammography did not reduce the number of advanced breast cancers found in women in the study. "This means that breast screening is unlikely to improve breast cancer survival or reduce the use of invasive surgery," said study author Dr. Karsten Juhl Jorgensen, deputy director of research for the Nordic Cochrane Center at the Rigshospitalet in Copenhagen. "It also means that breast screening leads to unnecessary detection and treatment of many breast cancers." Dr. Otis Brawley, chief ... Read more

Related support groups: Depo-Provera, Provera, Breast Cancer, Lupron, Medroxyprogesterone, Tamoxifen, Arimidex, Lupron Depot, Femara, Anastrozole, Letrozole, Megestrol, Evista, Zoladex, Megace, Herceptin, Aromasin, Casodex, Exemestane, Eligard

Many With Breast Cancer Unnecessarily Choose Double Mastectomy: Study

Posted 22 Dec 2016 by Drugs.com

WEDNESDAY, Dec. 21, 2016 – Many women with early stage breast cancer choose to have their healthy opposite breast removed, even when there are no medical indications that such a step is necessary, a new survey finds. That's especially true when the surgeon doesn't offer a recommendation either way, the researchers said. "We are seeing that one in six breast cancer patients are choosing bilateral mastectomy when this aggressive procedure is not going to benefit them in terms of survival," said Dr. Reshma Jagsi. Jagsi, who led the study, is a professor and deputy chair of radiation oncology at the University of Michigan School of Medicine. Cancer specialists say no compelling evidence suggests a survival advantage for most patients to chose a double mastectomy. Also, the risk of getting cancer in the opposite healthy breast is low for most patients, they note. However, after actress ... Read more

Related support groups: Surgery, Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Minority Women Less Likely to Get Breast Cancer Screening

Posted 16 Dec 2016 by Drugs.com

FRIDAY, Dec. 16, 2016 – Black and Hispanic women are less likely than white women to be screened for breast cancer, a large review finds. Screening rates for Asian/Pacific Islander and white women were similar, the research showed. The analysis of 39 studies including 6 million women was published Dec. 16 in the Journal of the American College of Radiology. "Not only do black and Hispanic women get screened less than white women, but disparities also persist in two age groups: women who are 40 to 65 years old, and 65 and older," study author Dr. Ahmed Ahmed said in a journal news release. "These findings are important; it's evident that more work needs to be done to ensure that all eligible women have access to this preventive screening tool," added Ahmed. He's a postdoctoral fellow researcher at the Mayo Clinic in Rochester, Minn. A great deal of effort has gone into finding racially ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer, Body Imaging

Beating Breast Cancer But Still Paying a Price

Posted 15 Dec 2016 by Drugs.com

THURSDAY, Dec. 15, 2016 – Women who survive breast cancer often experience lingering physical and emotional symptoms that go untreated, new research suggests. Ninety-two percent of long-term breast cancer survivors report at least three untreated symptoms for which they need assistance, according to the study. The most common unmet needs are achy joints, fatigue and weight gain – each affecting about one in four survivors in the study. Survivors living with more unmet needs are also more likely to experience anxiety and depression, the study found. Although the study involved just over 100 mostly white and college-educated women at one cancer center, the findings may be important for the nation's 2.8 million breast cancer survivors, the study authors suggest. When you extrapolate these results to the larger population of survivors, "it gets a lot worse very quickly," said lead author ... Read more

Related support groups: Anxiety and Stress, Breast Cancer, Psychiatric Disorders, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Breast Cancer Death Rates Vary Around the World

Posted 11 Dec 2016 by Drugs.com

FRIDAY, Dec. 9, 2016 – Breast cancer death rates are falling in the United States and many other countries, but increasing in South Korea and some Latin American countries, researchers report. The investigators looked at data from 47 countries from 1987 to 2013. They found that breast cancer death rates declined in 39 of those nations due to advances in detection and treatment over the past few decades. The largest decrease was in England and Wales, with a 46 percent drop. In the United States, the breast cancer death rate fell 42 percent. It dropped from 22 deaths per 100,000 women in 1987-1989 to 14 deaths per 100,000 women in 2011-2013, the study showed. Rates declined in all age groups in the United States: by 50 percent for women under 50; by 44 percent for women between 50 and 69; and by 31 percent for women 70 or older. There were mixed findings from Latin America. For example, ... Read more

Related support groups: Breast Cancer, Breast Cancer, Metastatic, Breast Cancer - Adjuvant, Breast Cancer, Prevention, Breast Cancer - Palliative, Osteolytic Bone Metastases of Breast Cancer

Page 1 2 3 4 Next

Ask a Question

Further Information

Related Condition Support Groups

Breast Cancer

Related Drug Support Groups

pamidronate, Aredia